Facebook Linkedin Twitter
Inside Precision Medicine YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Non-hodgkin lymphoma

Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
Oncology

YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Alice McCarthy
0
Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
News & Features

Mantle Cell Lymphoma Patients May Not Need Stem Cell Transplant

0
CAR T cell immunotherapy, illustration
News & Features

Outpatient CAR T Therapy Is Safe and Effective in Community Setting

0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Shortening of CAR-T Cell Monitoring Period Could Improve Accessibility

0
Hodgkin lymphoma, light micrograph
News & Features

CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma 

0
Immunoglobulin G—IgG—antibody molecule
News & Features

Frequent Immunoglobulin Testing Reduces Infections in CLL and NHL Patients

0
Diffuse large B-cell lymphoma
News & Features

Combination Targeted Therapy Regimen Potentially Practice-Changing for DLBCL

Laura Cowen
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Studies Address Risk for Secondary Cancers Related to CAR T Cell Therapy

0
CAR T cell immunotherapy
News & Features

New Technique Improves T Cell-Based Immunotherapies for Solid Tumors

Alice McCarthy
0
immune system
News & Features

Cullinan Nets $280M Investment and Targets CD19 in Lupus

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine